511 related articles for article (PubMed ID: 35225144)
1. Successful mRNA SARS-Cov-2 vaccine rechallenge after a first episode of immune thrombocytopenic purpura.
Chanut M; Jaidi R; Kohn M; Grange T; Brones C; Lombion N; Rousselot P; Longval T
Platelets; 2022 May; 33(4):652-653. PubMed ID: 35225144
[TBL] [Abstract][Full Text] [Related]
2. Treatment, outcome and re-vaccination of patients with SARS-CoV-2 vaccine-associated immune thrombocytopenia.
Ruzicka M; Wurm S; Lindner L; Dreyling M; von Bergwelt-Baildon M; Boeck S; Giessen-Jung C; Milani V; Stemmler JH; Subklewe M; Weigert O; Spiekermann K
Infection; 2023 Feb; 51(1):231-238. PubMed ID: 36195695
[TBL] [Abstract][Full Text] [Related]
3. Immune thrombocytopenia following COVID-19 mRNA vaccine: casuality or causality?
Pasin F; Calabrese A; Pelagatti L
Intern Emerg Med; 2022 Jan; 17(1):295-297. PubMed ID: 34100214
[No Abstract] [Full Text] [Related]
4. Thrombocytopenia including immune thrombocytopenia after receipt of mRNA COVID-19 vaccines reported to the Vaccine Adverse Event Reporting System (VAERS).
Welsh KJ; Baumblatt J; Chege W; Goud R; Nair N
Vaccine; 2021 Jun; 39(25):3329-3332. PubMed ID: 34006408
[TBL] [Abstract][Full Text] [Related]
5. [Immune thrombocytopenia after BNT162b2 mRNA COVID-19 vaccination].
Matsumura A; Katsuki K; Akimoto M; Sakuma T; Nakajima Y; Miyazaki T; Fujisawa S; Nakajima H
Rinsho Ketsueki; 2021; 62(11):1639-1642. PubMed ID: 34866090
[TBL] [Abstract][Full Text] [Related]
6. COVID-19 vaccine (mRNA BNT162b2) and COVID-19 infection-induced thrombotic thrombocytopenic purpura in adolescents.
Vorster L; Kirk SE; Muscal E; Despotovic JM; Cohen CT; Sartain SE
Pediatr Blood Cancer; 2022 Jun; 69(6):e29681. PubMed ID: 35373880
[TBL] [Abstract][Full Text] [Related]
7. Secondary immune thrombocytopenia supposedly attributable to COVID-19 vaccination.
Fueyo-Rodriguez O; Valente-Acosta B; Jimenez-Soto R; Neme-Yunes Y; Inclán-Alarcón SI; Trejo-Gonzalez R; García-Salcido MÁ
BMJ Case Rep; 2021 May; 14(5):. PubMed ID: 34059544
[TBL] [Abstract][Full Text] [Related]
8. Thrombotic thrombocytopenic purpura (TTP) after COVID-19 vaccination: A systematic review of reported cases.
Saluja P; Gautam N; Yadala S; Venkata AN
Thromb Res; 2022 Jun; 214():115-121. PubMed ID: 35533526
[TBL] [Abstract][Full Text] [Related]
9. Successful Treatment of Immune Thrombocytopenic Purpura with Intracranial Hemorrhaging and Duodenal Bleeding Following SARS-CoV-2 Vaccination.
Baba Y; Sakai H; Kabasawa N; Harada H
Intern Med; 2022 Jun; 61(12):1891-1895. PubMed ID: 35400701
[TBL] [Abstract][Full Text] [Related]
10. A Case Report of Immune Thrombocytopenia after ChAdOx1 nCoV-19 Vaccination.
Kim G; Choi EJ; Park HS; Lee JH; Lee JH; Lee KH
J Korean Med Sci; 2021 Nov; 36(43):e306. PubMed ID: 34751013
[TBL] [Abstract][Full Text] [Related]
11. Immune thrombocytopenic purpura secondary to COVID-19 vaccination: A systematic review.
Bidari A; Asgarian S; Pour Mohammad A; Naderi D; Anaraki SR; Gholizadeh Mesgarha M; Naderkhani M
Eur J Haematol; 2023 Apr; 110(4):335-353. PubMed ID: 36562217
[TBL] [Abstract][Full Text] [Related]
12. Thrombocytopenia following Pfizer and Moderna SARS-CoV-2 vaccination.
Lee EJ; Cines DB; Gernsheimer T; Kessler C; Michel M; Tarantino MD; Semple JW; Arnold DM; Godeau B; Lambert MP; Bussel JB
Am J Hematol; 2021 May; 96(5):534-537. PubMed ID: 33606296
[No Abstract] [Full Text] [Related]
13. Analysis of hematologic adverse events reported to a national surveillance system following COVID-19 bivalent booster vaccination.
Jacobs JW; Booth GS; Adkins BD
Ann Hematol; 2023 Apr; 102(4):955-959. PubMed ID: 36795118
[TBL] [Abstract][Full Text] [Related]
14. Immune Thrombocytopenia Following the Pfizer-BioNTech BNT162b2 mRNA COVID-19 Vaccine.
Ganzel C; Ben-Chetrit E
Isr Med Assoc J; 2021 Jun; 23(6):341. PubMed ID: 34155844
[No Abstract] [Full Text] [Related]
15. [Immune thrombocytopenia after BNT162b2 mRNA COVID-19 vaccination].
Sato K; Anayama M; Sumi M; Kobayashi H
Rinsho Ketsueki; 2021; 62(12):1688-1693. PubMed ID: 35022338
[TBL] [Abstract][Full Text] [Related]
16. Editorial: SARS-CoV-2 mRNA Vaccines and the Possible Mechanism of Vaccine-Induced Immune Thrombotic Thrombocytopenia (VITT).
Parums DV
Med Sci Monit; 2021 Apr; 27():e932899. PubMed ID: 33900279
[TBL] [Abstract][Full Text] [Related]
17. Severe case of refractory immune thrombocytopenic purpura requiring splenectomy after the COVID-19 vaccine.
Koilpillai S; Dominguez B; Khan A; Carlan S
BMJ Case Rep; 2022 Jun; 15(6):. PubMed ID: 35725277
[TBL] [Abstract][Full Text] [Related]
18. Acute immune thrombocytopenia following SARS-CoV-2 vaccination in chronic ITP patients and a healthy individual.
Ogai A; Yoshida R; Yuasa C; Chin K; Fujimaki K; Nakajima H
Int J Hematol; 2022 Feb; 115(2):293-295. PubMed ID: 34716890
[No Abstract] [Full Text] [Related]
19. First diagnosis of thrombotic thrombocytopenic purpura after SARS-CoV-2 vaccine - case report.
Osmanodja B; Schreiber A; Schrezenmeier E; Seelow E
BMC Nephrol; 2021 Dec; 22(1):411. PubMed ID: 34895163
[TBL] [Abstract][Full Text] [Related]
20. Relapse of immune thrombotic thrombocytopenic purpura (iTTP) possibly triggered by COVID-19 vaccination and/or concurrent COVID-19 infection.
Fang F; Tse B; Pavenski K
BMJ Case Rep; 2022 Jul; 15(7):. PubMed ID: 35902184
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
